Pulmonary Fibrosis News Forums Forums BioNews Content Flash Briefings & Podcasts AstraZeneca Turned to AI to Speed Discovery of New Medicines for IPF

  • AstraZeneca Turned to AI to Speed Discovery of New Medicines for IPF

    Posted by Charlene Marshall on June 24, 2019 at 12:26 pm

    The prognosis remains poor for patients living with idiopathic pulmonary fibrosis (IPF) and collaborations to enhance and expedite treatment options are crucial to patient survival. A recent collaboration has been announced by AstraZeneca to speed the discovery of new medicines for IPF, which is discussed in our latest flash briefing. To listen to the full briefing, click HERE.

    What are your thoughts on this flash briefing?

    An interesting, but complex and seemingly promising advancement for those of us living with IPF!

    Charlene Marshall replied 4 years, 9 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.